When to visit the vet?
Non-urgent see a veterinarian within 2–3 days
If the condition worsens / symptoms persist, consult a veterinarian.
Das Wichtigste auf einen Blick
A Leydig cell tumor is a testicular tumor in dogs that develops due to uncontrolled multiplication of Leydig cells in the testicle, which are responsible for testosterone production. The exact causes are still unclear, but genetic, hormonal, and environmental factors may play a role. Older dogs have an increased risk. Symptoms include palpable nodules in the testicle, reduced sex drive, and in rare cases difficulty urinating. Diagnosis involves clinical examinations, ultrasound, and tissue samples to determine the type and degree of malignancy of the tumor. Blood tests and scans can show whether the tumor has metastasized. The primary treatment is surgical removal of the affected testicle. Benign Tumors have a good prognosis, while malignant Tumors require a more cautious prognosis. Early detection improves the chances of recovery. Prevention is difficult because the causes are not fully understood, but regular veterinary examinations and a healthy lifestyle can help minimize the risk. Research focuses on genetic and molecular mechanisms, hormonal effects, and the development of new diagnostic and therapeutic approaches.
Ursachen
Leydig cells are specialized cells in the testicle responsible for producing testosterone. This hormone plays a crucial role in the development and maintenance of male reproductive organs and secondary sex characteristics. Leydig cell tumors occur when these cells multiply uncontrollably.
The exact causes of Leydig cell tumor development are not yet fully understood. Genetic factors may play a role, as can environmental factors or hormonal influences. A genetic predisposition could mean that some dog breeds are more susceptible to this type of tumor.
In addition, hormonal imbalances caused by other diseases or by taking certain medications can increase the risk of developing a Leydig cell tumor. Studies have also shown that older dogs have a higher risk of developing these Tumors, which points to the cumulative effects of aging processes and hormonal changes.
Symptoms
The symptoms of a Leydig cell tumor in dogs can vary and are often subtle. An enlargement of one or both testicles is often detected during a routine physical examination. This enlargement is often painless, but in some cases it can cause discomfort.
Another possible symptom is a Behavioral change in the dog due to hormonal changes caused by the tumor. This includes increased aggression or changes in sexual behavior. In rare cases, masculinization in female dogs or feminization in male dogs can occur, which may be expressed in the development of characteristics of the opposite sex.
In advanced cases—especially if the tumor is malignant and has metastasized—Weight loss, loss of appetite, and general weakness may occur. However, these symptoms are not specific to Leydig cell Tumors and can also occur with other conditions.
Diagnose
The diagnosis of a Leydig cell tumor usually begins with a thorough clinical examination, during which the veterinarian palpates the testicles and looks for anomalies. An enlargement or hardening of the testicle can be an indication of a tumor. The dog’s medical history is also taken into account, including any observed Behavioral changes and other symptoms.
For further clarification, imaging procedures such as ultrasound can be used to visualize the structure of the testicle and rule out other possible causes of the enlargement. However, a definitive diagnosis often requires a biopsy or surgical removal of the affected testicle for histopathological examination. This analysis makes it possible to determine the type of tumor and whether it is benign or malignant.
Additional diagnostic tests may include blood tests to measure hormone levels, as well as X-rays or CT scans to determine whether the tumor has metastasized. These tests help determine the stage of the tumor and develop the best treatment plan.
Therapie
The primary treatment for Leydig cell tumors in dogs is surgical removal of the affected testicle, also called an orchiectomy. This procedure is successful in most cases and can effectively remove both benign and malignant Tumors. For benign Tumors, this is often the only treatment needed.
For malignant Leydig cell Tumors, further treatment may be necessary, especially if metastasis is detected. This may include chemotherapy or radiation therapy, depending on the extent and location of the metastases. The specific treatment is tailored to the individual dog based on tumor size, stage, and the animal’s overall health.
After surgery and during any further treatment, regular follow-up is important to monitor healing and ensure there are no recurrences. Your veterinarian will recommend regular check-ups and possibly additional imaging tests to monitor the dog’s condition.
Prognose und Nachsorge
The prognosis for dogs with Leydig cell Tumors depends on several factors, including the type and stage of the tumor, the dog’s overall health, and how quickly treatment begins. Benign Leydig cell Tumors generally have a very good prognosis, especially when detected and treated early.
For malignant Tumors, the prognosis is more cautious, although many dogs can respond well to treatment, mainly if the tumor is not far advanced and has not yet metastasized. Early detection and treatment are crucial for improving survival chances and the affected dog’s quality of life.
Long-term monitoring and follow-up care are important to detect and treat possible recurrences or complications early. With appropriate care and regular veterinary check-ups, many dogs can live a normal, healthy life after treatment for a Leydig cell tumor.
Prävention
There are no specific measures for complete prevention of Leydig cell Tumors in dogs, as the exact causes are not yet fully understood. However, early castration / neutering can reduce the risk of testicular Tumors because it reduces testosterone production, which could be a possible factor in tumor development.
Regular veterinary examinations are crucial to detect changes in your dog’s health early. This includes regular checks of the testicles, especially in older dogs or dogs of certain breeds that may have a higher risk.
A healthy lifestyle, including a balanced diet and sufficient exercise, can promote your dog’s overall well-being and strengthen its immune system, which may reduce the risk of tumor development. It is also important to minimize Contact with potentially harmful environmental substances that could increase the risk of cancer.
Ausblick auf aktuelle Forschung
Research into Leydig cell Tumors in dogs is a dynamic field that is continuously making progress. Leydig cell Tumors are rare, but they offer valuable insights into endocrine and neoplastic processes in dogs. Currently, many studies focus on understanding the genetic and molecular biological mechanisms that lead to tumor formation. Researchers use state-of-the-art techniques such as genome sequencing and molecular markers to identify specific genetic mutations associated with the development of these Tumors. These genetic insights could lead to improved diagnostic tests and targeted therapies in the future.
Another important area of research is the investigation of the hormonal activity of Leydig cell Tumors. Since Leydig cells are responsible for testosterone production, scientists are investigating how these Tumors affect the hormonal balance in the dog’s body. These findings are particularly relevant because hormonal imbalances can lead to a variety of health problems. By understanding the hormonal changes caused by Leydig cell Tumors, researchers hope to develop better treatment strategies that take into account not only the tumor but also its systemic effects.
The development of new diagnostic methods is also an active area of research. Traditionally, Leydig cell Tumors have been diagnosed through histopathological examinations, which require a tissue sample from the affected testicle. Current research aims to develop less invasive diagnostic procedures, for example by using imaging techniques or specific biomarkers in the blood. These advances could make diagnosis easier and reduce stress for affected animals.
There is also promising progress in therapy development. While surgical removal of the tumor remains the most common treatment method, researchers are investigating alternative approaches such as radiation therapy and chemotherapy. These could be particularly important for advanced Tumors or metastases. Preclinical studies in animal models are being conducted to evaluate the effectiveness and safety of new therapeutic approaches. In the long term, these studies could lead to a broader range of therapy options for dogs with Leydig cell Tumors.
Finally, prevention is another important aspect of ongoing research. Since the exact cause of Leydig cell Tumors is still unclear, scientists are trying to identify predisposing factors. These include genetic predispositions, environmental factors, and dietary influences. The aim is to identify risk factors that could be minimized through targeted measures. Improved prevention could reduce the incidence of these Tumors and improve the overall health of the dog population.
Frequently Asked Questions (FAQs)
1. What is a Leydig cell tumor in dogs?
2. How common are Leydig cell Tumors in dogs?
3. What symptoms may indicate a Leydig cell tumor in dogs?
4. How is a Leydig cell tumor diagnosed?
5. What treatment options are available for Leydig cell Tumors in dogs?
6. Can Leydig cell Tumors in dogs be malignant?
7. Are there risk factors for developing Leydig cell Tumors in dogs?
8. Can castration / neutering reduce the risk of Leydig cell Tumors?
9. Are there preventive measures against Leydig cell Tumors in dogs?
10. What is the prognosis for dogs with a Leydig cell tumor?
Literatur
- Grieco, V., Riccardi, E., Greppi, G. F., Teruzzi, F., Iermanò, V., & Finazzi, M. (2008). Canine testicular tumours: A study on 232 dogs. Journal of Comparative Pathology, 138(2–3), 86–89. https://doi.org/10.1016/j.jcpa.2007.11.002
- Gazin, A. A., Vatnikov, Y. A., Sturov, N. V., Kulikov, E. V., Grishin, V., Krotova, E. A., Varentsova, A. A., Sapego, N. Y., Troshina, N. I., Byakhova, V. M., & Lisitskaya, K. V. (2022). Canine testicular tumors: An 11-year retrospective study of 358 cases in Moscow Region, Russia. Veterinary World, 15(2), 483–487. https://doi.org/10.14202/vetworld.2022.483-487
- Kudo, T., Kamiie, J., Aihara, N., Doi, M., Sumi, A., Omachi, T., & Shirota, K. (2019). Malignant Leydig cell tumor in dogs: Two cases and a review of the literature. Journal of Veterinary Diagnostic Investigation, 31(4), 557–561. https://doi.org/10.1177/1040638719854791
- Orlandi, R., Vallesi, E., Boiti, C., Polisca, A., Bargellini, P., & Troisi, A. (2022). Characterization of testicular tumor lesions in dogs by different ultrasound techniques. Animals, 12(2), Article 210. https://doi.org/10.3390/ani12020210
- Hayes, H. M., Jr., & Pendergrass, T. W. (1976). Canine testicular tumors: Epidemiologic features of 410 dogs. International Journal of Cancer, 18(4), 482–487. https://doi.org/10.1002/ijc.2910180413
- Nødtvedt, A., Gamlem, H., Gunnes, G., Grotmol, T., Indrebø, A., & Moe, L. (2011). Breed differences in the proportional morbidity of testicular tumours and distribution of histopathologic types in a population-based canine cancer registry. Veterinary and Comparative Oncology, 9(1), 45–54. https://doi.org/10.1111/j.1476-5829.2010.00231.x
- Liao, A. T., Chu, P.-Y., Yeh, L.-S., Lin, C.-T., & Liu, C.-H. (2009). A 12-year retrospective study of canine testicular tumors. Journal of Veterinary Medical Science, 71(7), 919–923. https://doi.org/10.1292/jvms.71.919
- Ramos-Vara, J. A., & Miller, M. A. (2009). Immunohistochemical evaluation of GATA-4 in canine testicular tumors. Veterinary Pathology, 46(5), 893–896. https://doi.org/10.1354/vp.08-VP-0287-R-BC
- Soto-Heras, S., Reinacher, L., Wang, B., Oh, J. E., Bunnell, M., Park, C. J., Hess, R. A., & Ko, C. J. (2024). Cryptorchidism and testicular cancer in the dog: Unresolved questions and challenges in translating insights from human studies. Biology of Reproduction, 111(2), 269–291. https://doi.org/10.1093/biolre/ioae075